ScreenerHero
GILDGilead Sciences, Inc.
NAS · US · Healthcare · Drug Manufacturers - General · gilead.com
124.81USD-0.05%Mkt Cap: 155.03B $P/E: 16.99

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, D…

Industry Peers

Drug Manufacturers - General
Screen all
vs Drug Manufacturers - General
P/E
Cheaper
P/B
Avg
Div Yield
Avg
1M Perf
Higher
LLY
Eli Lilly and Company
$982.77BUSDP/E 39.2
+832.4% 1M
JNJ
Johnson & Johnson
$556.77BUSDP/E 26.8
+85.9% 1M
ABBV
AbbVie Inc.
$406.29BUSDP/E 112.7
+834.2% 1M
RO
Roche Holding AG
$294.39BUSDP/E 20.2
-316.6% 1M
NOVNEE
Novartis AG
$267.10BUSDP/E 21.4
+82.1% 1M
MRK
Merck & Co., Inc.
$285.22BUSDP/E 32.5
+217.7% 1M
NOVN
Novartis AG
$261.94BUSDP/E 21.6
+87.2% 1M
AZN
AstraZeneca PLC
$251.74BUSDP/E 26.7
-398.9% 1M
AZN
AstraZeneca PLC
$224.03BUSDP/E 26.4
-511.2% 1M
NOVO-B
Novo Nordisk A/S
$193.45BUSDP/E 10.9
+400.5% 1M
AMGN
Amgen Inc.
$186.05BUSDP/E 24.0
+396.6% 1M
PFE
Pfizer Inc.
$142.94BUSDP/E 19.1
-275.3% 1M
BMY
Bristol-Myers Squibb Company
$111.70BUSDP/E 15.3
-656.0% 1M
SAN
Sanofi
$94.31BUSDP/E 18.3
-567.1% 1M
GSK
GSK plc
$83.84BUSDP/E 13.6
+52.2% 1M
BAYN
Bayer Aktiengesellschaft
$40.77BUSD
-187.6% 1M
MRV
Marvell Technology, Inc.
$32.03BUSDP/E 12.2
+5682.2% 1M
BIIB
Biogen Inc.
$29.48BUSDP/E 21.5
+634.2% 1M
REC
Recordati Industria Chimica e Farmaceutica S.p.A.
$11.28BUSDP/E 22.6
-58.5% 1M
ORNBV
Orion Oyj
$10.49BUSDP/E 18.2
-372.4% 1M
ORNAV
Orion Oyj
$10.49BUSDP/E 18.2
-338.5% 1M
GRF
Grifols, S.A.
$6.69BUSDP/E 14.8
-475.9% 1M
OGN
Organon & Co.
$3.52BUSDP/E 14.4
-44.6% 1M
VIRP
Virbac SA
$3.08BUSDP/E 18.8
-583.3% 1M
SCLX
Scilex Holding Company
$48.32MUSD
+1431.0% 1M
MIRA
MIRA Pharmaceuticals, Inc.
$39.98MUSD
-170.4% 1M
ELXR
Elixxer Ltd.
$9.51MUSD
+1666.7% 1M
ROSE
DocMorris AG
—
+1809.0% 1M
CELG-RI
Bristol-Myers Squibb Company Ce
—
FLXN
Horizon Flexible Income ETF
—P/E 27.4
+30.1% 1M
PHOO
Photocure ASA
—
FR0000140022
SANOFITP29OCT49
—
Indicators:|

Key Statistics

Company
Market Cap155.03B $
Enterprise Value165.93B $
Revenue (TTM)29.74B $
Gross Profit23.21B $
Net Income (TTM)8.51B $
Revenue/Share23.92 USD
Last Price124.81 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees17.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS3755581036
Valuation
P/E (Trailing)16.99
P/E (Forward)12.80
PEG2.14
EV/EBITDA11.26
EV/Revenue5.58
P/S5.17
P/B6.54
EPS (TTM)7.35
EPS (Forward)9.67
52W Range
104.4639% of range157.29
52W High157.29 USD
52W Low104.46 USD
Profitability
Gross Margin78.83%
Oper. Margin39.28%
EBITDA Margin49.56%
Profit Margin28.90%
ROE37.49%
ROA14.42%
Growth
Revenue Growth4.40%
Earnings Growth54.80%
Cash Flow & Leverage
Operating CF10.02B $
CapEx (TTM)563.00M $
FCF Margin26.68%
FCF Yield5.12%
Net Debt12.36B $
Net Debt/EBITDA0.84
Balance Sheet
Debt/Equity1.10
Current Ratio1.97
Quick Ratio1.54
Book Value/Sh18.93 USD
Cash/Share7.907 USD
Dividends
Fwd Div Rate3.280 USD
Trail. Div Rate3.190 USD
Div. Yield2.65%
5Y Avg Yield3.62%
Payout Ratio43.40%
Ex-Div DateJun 15, 2026
Pay DateJun 29, 2026
Splits
Last Split2:1
Split DateJan 28, 2013
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)157.57 USD
Upside (mean)+26.2%
Target Range122.00 USD – 180.00 USD
$122.00+26.2% to mean$180.00
# Analysts28
Ownership
Shares Out.1.24B
Float1.24B
Insiders0.12%
Institutions92.20%
Short Interest
Short Ratio3.9d
Short % Float2.07%
Short % Out.2.07%
Shares Short25.73M
Short (prev mo.)23.05M
Technical
SMA 50131.78 (-5.3%)
SMA 200129.40 (-3.5%)
Beta0.33
S&P 52W Chg24.49%
Avg Vol (30d)6.61M
Avg Vol (10d)9.60M
Technical Indicators
RSI (14)41.9
MACD-2.2132
MACD Signal-2.0529
MACD Hist.-0.1602
BB Upper136.92 USD
BB Middle128.56 USD
BB Lower120.21 USD
BB Width13.00%
ATR (14)3.466 USD
Vol Ratio (20d)1.17x